50
Participants
Start Date
July 7, 2025
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Ketamine Hydrochloride
Intravenous 0.5 mg/kg infusions of ketamine for three consecutive days, 24 hours apart, with no more than 1mg/kg or 60 mg/day regardless of body weight
Placebo
Intravenous 0.9% saline infusions for three consecutive days.
RECRUITING
Mayo Clinic Florida, Jacksonville
Lead Sponsor
Mayo Clinic
OTHER